Well Health - Digitale Services für die Medizin (Seite 4)

[winston-wolfe]

Antwort auf Beitrag Nr.: 75.002.363 von Chash-Carry am 21.12.23 17:48:47

Wie der cbdexperte erklärt könnte es an der dünnen Marge liegen. Ich denke das wird sich mittelfristig bessern, derzeit ist Well Health aggressiv auf Expansionskurs und steckt Claims ab, das kostet viel Geld.
Generell bewegt sich Well mMn in einem Wachstumsmarkt, wenn sie sich nicht verzocken sollte die Story weiter gehen.

All the Best allen Investierten 😎

Zitat von Chash-Carry: Hallo winston-wolfe siehst du hier irgendwo dunkle Wolken? Oder ist das dem Steuersystem in Kanada geschuldet? Hast du oder jemand anderes eine new's für den Verlauf? Danke

[Chash-Carry]

Hallo winston-wolfe siehst du hier irgendwo dunkle Wolken? Oder ist das dem Steuersystem in Kanada geschuldet? Hast du oder jemand anderes eine new's für den Verlauf? Danke

[winston-wolfe]

“Just too low”: Raymond James raises target price on WELL Health

WELL Health It’s a digital health stock that trades like a railroad and Raymond James analyst Michael W. Freeman has a problem with that.

On November 30, in a research update to clients, Freeman maintained his “Outperform 2” rating but raised his target price on WELL Health Technologies (WELL Health Technologies Stock Quote, Chart, News, Analysts, Financials TSX:WELL) from $8.50 to $9.00, implying a return of 137.5 per cent at the time of publication.

The analyst explained the reasoning behind his decision.

“The way we see it, WELL has established a path to dominating primary healthcare in Canada, carving out a defensible niche in U.S. specialty care, and leaning deep into AI-enabled care provision, all at the same time,” he wrote. “WELL’s diversified, fast-growing, and profitable platform offers investors well-insulated exposure to the North American healthcare provider sector, and we think this is worth well in excess of 1x FY24 P/S (where the stock is now).”
...
https://www.cantechletter.com/2023/11/just-too-low-raymond-j…

[winston-wolfe]

3 Reasons I’m Buying WELL Health Stock Today

With WELL Health consistently growing its sales and profitability while continuing to lose value, it’s one of the best stocks to buy now.
...
https://www.fool.ca/2023/11/22/3-reasons-im-buying-well-heal…

[cbdexperte]

Antwort auf Beitrag Nr.: 74.812.937 von Chash-Carry am 15.11.23 22:16:01

Well investiert und wächst organisch aber die Umsatzsteigerungen haben eben noch kein Wachstum der Gewinne zur Folge. Das lässt den Kurs immer wieder „abschmieren“. Trotz enormer Umsatzsteigerungen geht das bereinigte EBITDA gegenüber dem letzten Jahr zurück und der Verschuldungsgrad sinkt nur marginal.

[Chash-Carry]

Kann mir jemand bitte erklären was hier passiert ist??? Warum schmiert der Kurs so ab??? Topp Ergebnis super Aussicht mega Zahlen und trotzdem schafft es der Kurs nicht über 4 € Warum??

[winston-wolfe]

Hoffe die Zahlen schlagen sich bald deutlicher im Kurs wieder

WELL Health Reports Record Results for Q3-2023, Raises Guidance for Balance of 2023 and Provides Guidance of Over $900 Million in Revenue for 2024

WELL achieved record quarterly revenues of $204.5 million and record Adjusted EBITDA(1) of $28.2 million in Q3-2023. This was WELL's 19th consecutive quarter of record revenue performance.
WELL surpassed a total of 1.03 million patient visits(2) in Q3-2023, and the Company achieved almost 1.58 million total care interactions(2) representing approximately 6.32 million care interactions on an annualized run-rate basis.
WELL's Canadian business continues to experience significant organic growth and profitability generating Adjusted EBITDA of $12.3 million in Q3 2023 a YoY increase of 24%.
WELL is upgrading its guidance with the expectation that 2023 revenue will be between $755 million to $765 million reflecting improved organic growth expectations for the balance of the year.
WELL expects to exceed $900 million in annual revenue in 2024 through organic growth. WELL also anticipates continued and sustained gains in Adjusted EBITDA and cash flow.

VANCOUVER, BC, Nov. 14, 2023 /PRNewswire/ - WELL Health Technologies Corp. (TSX: WELL) (OTCQX: WHTCF) (the "Company" or "WELL"), a digital healthcare company focused on positively impacting health outcomes by leveraging technology to empower healthcare practitioners and their patients globally, is pleased to announce its interim consolidated financial results for the quarter ended September 30, 2023 .

Hamed Shahbazi, Founder and CEO of WELL commented, "Q3 was an outstanding quarter for us, as we achieved record patient visits, Adjusted EBITDA(1) and posted our first quarter ever with more than $200M in revenues. While all our business units are executing extremely well, our Canadian business grew its Adjusted EBITDA by 24% and shows no signs of slowing down. We are expecting to have strong performance for the remainder of 2023 and into next year. We are ahead of our plan for reaching one billion in revenue and feel confident in introducing our guidance for 2024 of achieving over $900 million in annual revenue driven by organic growth. The backbone of our success has been the Company's continued focus on tech enabling healthcare providers and supporting them in simplifying their work lives, modernizing, and digitizing their clinical practices and delivering the best healthcare possible."
...
https://www.finanznachrichten.de/nachrichten-2023-11/6065767…

[winston-wolfe]

und weiter geht's

WELL Health Launches "WELL Longevity+" A Program Designed to Provide the Most Advanced Preventative Care Available

WELL Health announces the launch of the WELL Longevity+ Program, enhancing preventative health with advanced precision diagnostics and AI technologies for the early detection of serious health conditions.
The WELL Longevity+ preventative care program uses the latest cutting-edge diagnostic technology to dramatically improve early diagnosis of major chronic diseases, which are often the leading causes of death and disability, paving the way for earlier treatment interventions.
Initially available at the newly inaugurated WELL Health Medical & Longevity Centre in Vancouver, BC, offering a wide range of precision diagnostic testing.
Expansion plans include rolling out WELL Longevity+ services through WELL Health's network of preventative health clinics throughout Canada.
...
https://www.newswire.ca/news-releases/well-health-launches-w…

[winston-wolfe]

...

And while there are several high-quality growth stocks for Canadian investors to buy now, WELL has consistently shown it’s one of the best of the best.

For example, in 2022, even after many of the pandemic tailwinds were no longer benefitting WELL, the stock still managed to grow its sales by a whopping 88% year over year. And this year, analysts estimate WELL’s revenue will grow by another 33%.

This growth is significant because WELL is now working on improving its profitability. So, it’s not just an early-stage healthcare tech stock anymore.

Another reason WELL Health is one of the top Canadian stocks to buy now is that it serves one of the most defensive and reliable industries there is.

So, while many tech stocks like it could struggle in these environments, because WELL serves the healthcare sector, it can continue to grow its operations.

For example, this morning, WELL announced that it once again saw a record number of patients in the third quarter, which, unsurprisingly, led to another quarter of record revenue generation for the stock.

So, the fact that it’s such a high-quality growth stock and the fact that it serves such a defensive industry is making WELL one of the cheapest stocks on the market today.

...
https://www.fool.ca/2023/11/07/down-30-over-the-last-6-month…

[winston-wolfe]

WELL Health Announces Record Patient Visits and Total Care Interactions for Q3-2023 Resulting in Record Quarterly Revenue

WELL expects to announce record quarterly revenue in Q3-2023, underpinned by record care metrics which includes record patient visits1 of over 1.03 million and almost 1.58 million Total Care Interactions3, which now includes Billed Provider Hours.
This quarter's strong performance was driven by organic growth as well as a full quarter of recently announced acquisitions. Q3-2023 will be WELL's 19th consecutive quarter of record quarterly revenues.
Following the acquisition of CarePlus at the beginning of Q3, which included staffing and locum tenens services branded under "RADAR Healthcare Providers", WELL now reports metrics associated with Billed Provider Hours.
WELL will announce its Third Quarter 2023 Financial Results on November 14, 2023. Conference call details are provided below.
...
https://www.newswire.ca/news-releases/well-health-announces-…